The Compounding Pharmacy of America product recalled over sterility concerns
- Recall date
- June 2, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- The Compounding Pharmacy of America recalls Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable, The Compounding Pharmacy of America, Knoxville, TN
- Recall number
- D-1805-2015
- FDA classification
- Class II
- Brand / firm
- The Compounding Pharmacy of America
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable, The Compounding Pharmacy of America, Knoxville, TN
Get recall alerts
Free email alert whenever The Compounding Pharmacy of America has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Compounding Pharmacy of America